CEO Aryan Goyal resigns from Nureca, stake transfers to Saurabh Goyal
NURECA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 1.6 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Mr. Aryan Goyal has resigned as Whole-time Director and CEO of Nureca Limited with effect from July 1, 2026. The resignation follows a Family Settlement Agreement dated June 17, 2026 among family members, under which his entire shareholding in the company is being concurrently transferred to Mr. Saurabh Goyal. No other material reasons for the resignation have been disclosed.
Top-level leadership exit tied to family settlement and full stake transfer to Saurabh Goyal. Investors should watch for succession plan and any strategic shifts.